BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MALAT1, PRO1073, 378938, Q9UHZ2
65 results:

  • 1. Mechanistic actions of long non-coding RNA malat1 within the ovary and at the feto-maternal interface.
    Adu-Gyamfi EA; Cheeran EA; Salamah J; Lee BK
    Mol Biol Rep; 2024 Feb; 51(1):301. PubMed ID: 38353828
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long Non-Coding RNAs: Bridging cancer-Associated Thrombosis and Clinical Outcome of Ovarian cancer Patients.
    Marques IS; Tavares V; Savva-Bordalo J; Rei M; Liz-Pimenta J; de Melo IG; Assis J; Pereira D; Medeiros R
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203310
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. METTL16 Inhibits the Malignant Progression of Epithelial Ovarian cancer through the lncRNA malat1/
    Li C; Liu J; Lyu Y; Ling S; Luo Y
    Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas.
    Ghafouri-Fard S; Abbasi F; Nicknam A; Hussen BM; Eslami S; Akbari Dilmaghani N; Taheri M; Sharifi G
    Pathol Res Pract; 2023 Aug; 248():154573. PubMed ID: 37270938
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic cancer.
    Jiang W; Du Y; Zhang W; Zhou W
    Can J Gastroenterol Hepatol; 2022; 2022():4661929. PubMed ID: 36406148
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Long Non-Coding RNAs Profiling Using Microarray in Papillary Thyroid Carcinoma.
    Islam F; Zhou Y; Lam AK
    Methods Mol Biol; 2022; 2534():135-148. PubMed ID: 35670973
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Splice-Variant Knock-Out of TGFβ Receptors Perturbates the Proteome of Ovarian Carcinoma Cells.
    Jacobs Catane L; Moshel O; Smith Y; Davidson B; Reich R
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884451
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. LncRNA malat1 Facilitates Ovarian cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
    Mao TL; Fan MH; Dlamini N; Liu CL
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PTCH1-GLI1 Fusion-Positive Ovarian Tumor: Report of a Unique Case With Response to Tyrosine Kinase Inhibitor Pazopanib.
    Alwaqfi RR; Samuelson MI; Guseva NN; Ouyang M; Bossler AD; Ma D
    J Natl Compr Canc Netw; 2021 Sep; 19(9):998-1004. PubMed ID: 34551385
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long noncoding RNAs: role and contribution in pancreatic cancer.
    Ramya Devi KT; Karthik D; Mahendran T; Jaganathan MK; Hemdev SP
    Transcription; 2021 Feb; 12(1):12-27. PubMed ID: 34036896
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer.
    Luzón-Toro B; Villalba-Benito L; Fernández RM; Torroglosa A; Antiñolo G; Borrego S
    Orphanet J Rare Dis; 2021 Jan; 16(1):4. PubMed ID: 33407723
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. LncRNAs in Ovarian cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
    Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Combined molecular and mathematical analysis of long noncoding RNAs expression in fine needle aspiration biopsies as novel tool for early diagnosis of thyroid cancer.
    Possieri C; Locantore P; Salis C; Bacci L; Aiello A; Fadda G; De Crea C; Raffaelli M; Bellantone R; Grassi C; Strigari L; Farsetti A; Pontecorvi A; Nanni S
    Endocrine; 2021 Jun; 72(3):711-720. PubMed ID: 33030666
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Regulation of a long noncoding RNA malat1 by aryl hydrocarbon receptor in pancreatic cancer cells and tissues.
    Lee JE; Cho SG; Ko SG; Ahrmad SA; Puga A; Kim K
    Biochem Biophys Res Commun; 2020 Nov; 532(4):563-569. PubMed ID: 32900487
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long Noncoding RNA Expression in Adrenal Cortical Neoplasms.
    Shiyanbola O; Hardin H; Hu R; Eickhoff JC; Lloyd RV
    Endocr Pathol; 2020 Dec; 31(4):385-391. PubMed ID: 32725507
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Long Non-Coding RNA malat1 Enhances Ovarian cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
    Wu X; Wang Y; Zhong W; Cheng H; Tian Z
    Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
    Peng Y; Fang X; Yao H; Zhang Y; Shi J
    Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
    [No Abstract]    [Full Text] [Related]  

  • 18. RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions.
    Kumar SR; Kimchi ET; Manjunath Y; Gajagowni S; Stuckel AJ; Kaifi JT
    Sci Rep; 2020 Feb; 10(1):2800. PubMed ID: 32071328
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib.
    Eismann J; Heng YJ; Waldschmidt JM; Vlachos IS; Gray KP; Matulonis UA; Konstantinopoulos PA; Murphy CJ; Nabavi S; Wulf GM
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):503-514. PubMed ID: 31745703
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. malat1 rs619586 polymorphism functions as a prognostic biomarker in the management of differentiated thyroid carcinoma.
    Wang ML; Liu JX
    J Cell Physiol; 2020 Feb; 235(2):1700-1710. PubMed ID: 31456244
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.